Wednesday, April 21, 2021
Home Clinical Research Coronavirus treatment: List of Vaccines and drugs in the pipeline for COVID-19

Coronavirus treatment: List of Vaccines and drugs in the pipeline for COVID-19

As the number of confirmed cases of COVID-19 continues to rise, healthcare researchers around the world are working tirelessly to discover new life-saving innovations in medicine.

Here are some companies and institutions developing new treatment options for COVID-19

Vaccine Company name Type of Vaccine Phase of study Study link
mRNA1273  (2019-nCoV Vaccine)   Emory University in Atlanta RNA Phase I
Ad5-nCoV Cansino Bio  Non replicating viral vector Phase I
  chadox1 ncov19 University of Oxford Non replicating viral vector Phase I/II
LVSMENP-DC Shenzhen Geno immune medical institute lentiviral Phase I/II
BCG vaccines (Bacille Calmette-Guérin)   Murdoch Childrens Research Institute. Live Attenuated virus Phase II/III
     Drug Company name Mechanism of action Phase of study Study link
EUSA Pharma interleukin (IL)-6 inhibitor Observational study  
Gimsilumab Roivant monoclonal antibody targeting GM-CSF Phase I
Losartan Univ. of Minnesota ANGIOTENSIN TYPE 1 RECEPTOR inhibitor Phase II
AiRuiKa (camrelizumab) Southeast Univ China PD-1 inhibitor Phase II
Fingolimod    First Affiliated Hospital of Fujian Medical University Sphingosine 1-phosphate receptor modulator Phase II
SNG001 Synairgen IFN-beta 1a Sphingosine phosphate receptor modulator Phase II
Kaletra AbbVie’s HIV protease. Failed trial
Ganovo + Ritonavir Ascletis HCV NS3/4A protease inhibitor. Phase IV
Actemra (Tocilizumab) Roche IL-6 receptors inhibitor Phase III  
CD24Fc Oncoimmune  modulate immune  responses Phase III
Prezcobix Shanghai Public health clinical centre HIV protease inhibitor Phase III
Colchine The Montreal Heart Institute (MHI) Research Centre Tubulin Disruption Phase III
Kevzara (sarilumab) Sanofi and Regeneron IL-6 receptor Phase 2/3
 Hydroxychloroquine University of Minnesota ACE2 inhibitor Phase II/III  
Avigan FUJIFILM RNA polymerase inhibitor Phase III
Avastin (Bevacizumab)  Qilu Hospital of Shandong University VEGF inhibitor Phase 2/3
Remdesivir Gilead Adenosine analouge Phase III
Leronlimab (PRO140) CytoDyn CCR5antagonist Phase 2b/3
Aviptadil NeuroRx IL-6 inhibitor Phase II


Phase III

Mesenchymal stem cells
various instituteTissue regenerationPhase I
- Advertisement -


Please enter your comment!
Please enter your name here

15 + 4 =

Most Popular

Chemotherapy-free treatment option to be offered to patients with England’s most common leukaemia

April 21, 2021: A brand new oral treatment for an incurable blood cancer has been recommended for NHS use by NICE.

GW Pharma receives EU approval for EPIDYOLEX® for treatment of seizures

April 20, 2021: "GW Pharmaceuticals, a world leader in discovering, developing and delivering regulatory approved cannabis-based medicinesannounces that the European Commission has...

Amgen Successfully Completes Acquisition Of Five Prime Therapeutics

April 16, 2021: "Amgen announced that it has successfully completed its previously announced tender offer to purchase all outstanding shares of...

JCVI issues new advice on COVID-19 vaccination for pregnant women

April 16, 2021: There have been no specific safety concerns identified with any brand of coronavirus (COVID-19) vaccines in relation to pregnancy.